| 804 |
Centers for Disease Control and Prevention |
Html |
en |
Zinc Deficiency-Associated Dermatitis in Infants During aNationwide Shortage of Injectable Zinc - Washington, DC, andHouston, Texas, 2012-2013 |
Please note: An erratum has been published for this article. To view the erratum, please click here. |
| zinc demand | 0.347955 |
| vulnerable infants | 0.276212 |
| Zinc deficiencies | 0.345978 |
| injectable zinc solution | 0.410267 |
| PN micronutrient components | 0.287804 |
| chronic zinc deficiency | 0.400293 |
| infants experienced zinc | 0.436572 |
| receiving zinc-deficient PN | 0.287213 |
| insufficient zinc | 0.371717 |
| low serum zinc | 0.454731 |
| serum zinc levels | 0.475777 |
| American Regent | 0.268325 |
| additional cases | 0.291076 |
| premature infants | 0.396079 |
| infants | 0.450609 |
| alkaline phosphatase levels | 0.330629 |
| zinc-deficient PN | 0.386483 |
| birth weight infants | 0.319094 |
| injectable zinc supplies | 0.430275 |
| micronutrient deficiency | 0.288947 |
| micronutrient deficiencies | 0.279131 |
| injectable zinc sulfate | 0.447986 |
| injectable zinc shortage | 0.479485 |
| serum zinc level | 0.495114 |
| full-term infants | 0.278934 |
|
| low alkaline phosphatase | 0.275856 |
| FDA | 0.273832 |
| zinc absorption | 0.345296 |
| injectable zinc compounds | 0.412118 |
| injectable zinc supplements | 0.424358 |
| zinc deficient | 0.372308 |
| Drug Administration | 0.265204 |
| injectable zinc | 0.849199 |
| trace element toxicity | 0.281687 |
| permanent gastrointestinal dysfunction | 0.27665 |
| parenteral trace elements | 0.288428 |
| parenteral nutrition | 0.267996 |
| gastrointestinal dysfunction | 0.283048 |
| medically compromised infants | 0.313054 |
| injectable zinc product | 0.396104 |
| below-normal serum zinc | 0.386194 |
| injectable products | 0.265632 |
| zinc shortages | 0.372481 |
| zinc supports | 0.346798 |
| systemic zinc reserves | 0.360474 |
| zinc deficiency disorder | 0.926802 |
| acute zinc deficiency | 0.417196 |
| low birth weight | 0.292646 |
| cholestatic infants | 0.286973 |
|
CLICK HERE |
| 899 |
Centers for Disease Control and Prevention |
Html |
en |
10 Reasons To Get Vaccinated | CDC Features |
Did you know that adults need vaccines too? If you didn’t, you are not alone. |
| certain diseases | 0.730151 |
| babysitters | 0.530068 |
| lung disease | 0.634524 |
| pertussis | 0.567263 |
| dozen diseases | 0.623326 |
| number | 0.52936 |
| best protection | 0.644129 |
| shingles | 0.528558 |
| health conditions | 0.620004 |
| financial costs | 0.618843 |
| important reasons | 0.644998 |
| exciting opportunities | 0.624069 |
| work | 0.587243 |
| diseases | 0.770347 |
| medical visits | 0.624779 |
| contagious diseases | 0.632113 |
| additional vaccines | 0.733433 |
| great memories | 0.625873 |
| Adult vaccines | 0.723472 |
| influenza | 0.600751 |
| death | 0.526809 |
| vaccines | 0.96786 |
| chronic health condition | 0.735515 |
| adults | 0.637123 |
| waste time | 0.624563 |
|
| U.S. | 0.560382 |
| heart disease | 0.636508 |
| immunizations | 0.527474 |
| health departments | 0.613698 |
| disease | 0.788721 |
| complications | 0.581177 |
| hospitalization | 0.528991 |
| advantage | 0.52696 |
| meningitis | 0.528042 |
| certain vaccine-preventable diseases | 0.765892 |
| weakened immune systems | 0.756854 |
| travel checklist | 0.615261 |
| newborns | 0.527106 |
| doctor’s offices | 0.611773 |
| Talk | 0.563314 |
| certain vaccines | 0.740709 |
| people | 0.586238 |
| chronic conditions | 0.624894 |
| whooping cough | 0.7876 |
| long-term illness | 0.633992 |
| baby | 0.527053 |
| risk | 0.655783 |
| time | 0.663481 |
| severe illness | 0.629995 |
|
CLICK HERE |
| 5524 |
Centers for Disease Control and Prevention |
Html |
en |
Chlorobromomethane - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5905 |
Centers for Disease Control and Prevention |
Html |
en |
Di-sec octyl phthalate - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7504 |
Centers for Disease Control and Prevention |
Html |
en |
Healthy Housing Reference Manual - Chapter 1 Figures |
NCEH provides leadership to promote health and quality of life by preventing or controlling those diseases, birth defects, or disabilities resulting from interaction between people and the environment. Site has information/education resources on a broad range of topics, including asthma, birth defects, radiation, sanitation, lead in blood, and more. |
| MPEG | 0.741242 |
| site | 0.541063 |
| PDF | 0.544429 |
|
|
CLICK HERE |
| 8008 |
Centers for Disease Control and Prevention |
Html |
en |
Flu Partner Success Stories: Richmond City Health District |
Partner success stories, Richmond City Health District - CDC |
| Assistant Director | 0.391124 |
| steward | 0.319547 |
| University executive assistant | 0.454434 |
| city agencies | 0.417865 |
| media department | 0.383595 |
| campus resources | 0.383708 |
| poorest citizens | 0.388044 |
| broadcast media | 0.398615 |
| underclass population | 0.394236 |
| Health District comments | 0.489947 |
| understanding | 0.315923 |
| heart problems | 0.385631 |
| unique outreach agenda | 0.469507 |
| housing council representative | 0.613419 |
| partnership growth | 0.399456 |
| public housing council | 0.607438 |
| city’s housing | 0.409295 |
| Vice President | 0.379859 |
| Richmond City Health | 0.914868 |
| support | 0.315908 |
| CDC campaign | 0.466358 |
| vital partner | 0.377024 |
| mini clinics | 0.38611 |
| broad-based value | 0.387499 |
| chronic health conditions | 0.47233 |
|
| great strides | 0.412383 |
| college community | 0.38563 |
| Virginia Union University | 0.603169 |
| African American print | 0.481828 |
| people resources | 0.383458 |
| Marilyn Fleming | 0.383535 |
| nurse | 0.331442 |
| life-line | 0.327419 |
| public awareness | 0.406466 |
| student volunteerism | 0.387912 |
| public education | 0.388069 |
| CDC flu vaccination | 0.529945 |
| African American city | 0.475765 |
| CDC immunization campaign | 0.513037 |
| partnership development | 0.401949 |
| health department | 0.408211 |
| Sports players | 0.38092 |
| Dr. Danny Avula | 0.475262 |
| church ministries | 0.398631 |
| VUU | 0.326854 |
| pulse | 0.336292 |
| pathway | 0.31624 |
| campaign kick-off | 0.425515 |
| varied sectors | 0.385697 |
|
CLICK HERE |
| 8081 |
Centers for Disease Control and Prevention |
Html |
en |
Media Relations - MMWR News Synopsis: February 14, 2013 |
CDC Media Relations - MMWR News Synopsis: January 31, 2013 |
| current treatment guidelines | 0.685902 |
| Motor Vehicle Traffic | 0.676893 |
| chronic infections | 0.632655 |
| untreatable gonorrhea | 0.815751 |
| gonorrhea treatment guidelines | 0.806504 |
| cannabinoid compounds | 0.658225 |
| cannabinoid-related acute kidney | 0.709525 |
| Michigan surveillance data | 0.719636 |
| recent laboratory data | 0.686011 |
| chronic hepatitis cohort | 0.755158 |
| Hepatitis B virus | 0.649023 |
| National Center | 0.701793 |
| Salmonella Bredeney Infections | 0.683028 |
| TB Prevention | 0.710808 |
| Gonorrhea infections | 0.729886 |
| synthetic drug | 0.636903 |
| synthetic cannabinoid products | 0.911262 |
| urban health care | 0.710983 |
| public health officials | 0.715013 |
| unique cannabinoid | 0.664709 |
| Carbapenem-Resistant Klebsiella pneumoniae | 0.687763 |
| News Media Line | 0.867882 |
| Synthetic cannabinoids | 0.648631 |
| viral hepatitis disease | 0.754902 |
| state surveillance system. | 0.70294 |
|
| long resistance history | 0.672794 |
| United States | 0.783275 |
| HCV infection | 0.620177 |
| risk factor data | 0.696722 |
| older cases | 0.634587 |
| Electronic Media | 0.621924 |
| adverse health effects | 0.715771 |
| public health concern | 0.723402 |
| Community Health | 0.624503 |
| CDC
Division | 0.664085 |
| New Delhi Metallo-Beta-Lactamase | 0.676822 |
| HCV cases | 0.66102 |
| viral hepatitis surveillance | 0.765465 |
| provider-based electronic reporting | 0.696234 |
| viral hepatitis | 0.887411 |
| national surveillance systems. | 0.707627 |
| synthetic marijuana | 0.641719 |
| CDC researchers | 0.642824 |
| sixteen cases | 0.652891 |
| proper antibiotic treatment | 0.68742 |
| gonorrhea cases | 0.750098 |
| cephalosporin-resistant gonorrhea | 0.705015 |
| chronic HBV cases | 0.76666 |
| basic demographic data | 0.694865 |
|
CLICK HERE |
| 8247 |
Centers for Disease Control and Prevention |
Html |
en |
Blood Disorders in Women, About Us - NCBDDD |
null |
| blood disorders | 0.770877 |
| CDC | 0.728127 |
| robust testing methods | 0.509475 |
| health plans | 0.452554 |
| health care provider | 0.600658 |
| special data collection | 0.541314 |
| innovative testing methods | 0.518918 |
| management options | 0.43518 |
| Disease Control | 0.434516 |
| outreach activities | 0.417481 |
| national levels | 0.422045 |
| state health departments | 0.546573 |
| Building lab capacity | 0.503225 |
| Previous CDC studies | 0.604844 |
| health care providers | 0.558811 |
| health care centers | 0.565986 |
| HTC network | 0.414594 |
| health care professionals | 0.732804 |
| quality diagnostic resources | 0.5048 |
| Hemophilia Treatment Centers | 0.579352 |
| postpartum bleeding | 0.603976 |
| community-based organizations | 0.417039 |
| laboratory research | 0.415834 |
| reproductive health | 0.451834 |
|
| low consumer awareness | 0.51625 |
| standard testing protocols | 0.514835 |
| disorders affecting women | 0.596458 |
| blood disorder characteristics | 0.537872 |
| women | 0.690271 |
| menstrual bleeding | 0.607482 |
| coagulation testing | 0.424167 |
| laboratory services | 0.492245 |
| new monitoring initiative | 0.521592 |
| health promotion | 0.449922 |
| reproductive outcomes | 0.417064 |
| diagnostic testing techniques | 0.568898 |
| public health approach | 0.726764 |
| public awareness campaign | 0.52551 |
| proper diagnosis | 0.51878 |
| health care | 0.900303 |
| platelet function disorders | 0.542602 |
| Community Counts | 0.419299 |
| data collection | 0.820733 |
| public health-related information | 0.527309 |
| blood supply | 0.45385 |
| national testing standards | 0.520778 |
| research studies | 0.42491 |
| definitive diagnosis | 0.426577 |
|
CLICK HERE |
| 12191 |
Centers for Disease Control and Prevention |
Html |
en |
National Early Season Flu Vaccination Coverage, United States, November 2014 |
Results from the November 2014 National Influenza Flu Survey, United States for the 2014-15 influenza season - CDC |
| short flu module | 0.328988 |
| early season flu | 0.458885 |
| vaccination campaigns | 0.298746 |
| survey interviewers conduct | 0.245975 |
| season flu vaccination | 0.52377 |
| telephone number resolution | 0.244231 |
| Risk Factor Surveillance | 0.276419 |
| United States population | 0.245437 |
| Internet Flu Survey | 0.360552 |
| Page | 0.276206 |
| final end-of-season coverage | 0.290381 |
| cellular telephone survey | 0.249385 |
| internet panel survey | 0.277054 |
| children | 0.326874 |
| NIFS data | 0.2847 |
| flu vaccination-related data | 0.333861 |
| vaccination estimates | 0.328543 |
| flu vaccination | 0.919325 |
| racial/ethnic group differences | 0.249062 |
| National Immunization Survey-Flu | 0.286811 |
| National Early Season | 0.268901 |
| early season differences | 0.27223 |
| racial/ethnic groups | 0.262304 |
| end-of-season coverage estimates | 0.303734 |
| non-Hispanic black adults | 0.257643 |
|
| racial/ethnic differences | 0.262877 |
| season vaccination coverage | 0.393928 |
| flu vaccination status | 0.408707 |
| Behavioral Risk Factor | 0.276487 |
| flu season vaccination | 0.484094 |
| United States | 0.35016 |
| adults | 0.325714 |
| flu vaccine | 0.3291 |
| flu vaccination coverage | 0.91911 |
| early season estimates | 0.372899 |
| flu season estimates | 0.416929 |
| adult estimates | 0.281067 |
| National Influenza Vaccination | 0.325429 |
| Influenza Season | 0.254088 |
| NIFS estimates | 0.284103 |
| non-Hispanic white adults | 0.257629 |
| NIS-Flu estimates | 0.268894 |
| child age groups | 0.24513 |
| flu vaccinations | 0.320262 |
| similar coverage | 0.244766 |
| NIS-Flu data | 0.264324 |
| different data sources | 0.248896 |
| Adult NIFS data | 0.271993 |
| end-of-season estimates | 0.297134 |
|
CLICK HERE |
| 13144 |
Centers for Disease Control and Prevention |
Html |
en |
Sinus Rinsing & Neti Pots | Prevention & Control | Naegleria fowleri |
Education and information about the brain eating ameba Naegleria fowleri that causes encephalitis and death including frequently asked questions, biology, sources of infection, diagnosis, treatment, prevention and control, and other publications and pertinent information for the public and medical professionals. |
| visibly cloudy water | 0.525598 |
| nasal rinsing devices | 0.748551 |
| bleach disinfection protocol | 0.552468 |
| sinus rinse bottle | 0.461534 |
| amebic meningoencephalitis death | 0.47918 |
| clear well water | 0.454302 |
| sinus rinsing | 0.477762 |
| solid chlorine tablets | 0.591371 |
| 5-fold safety factor* | 0.434739 |
| primary amoebic meningoencephalitis | 0.462435 |
| public drinking water | 0.516303 |
| clear water | 0.541948 |
| Filter water | 0.468767 |
| hypochlorite fact sheet | 0.455332 |
| additional safety factor | 0.559502 |
| calcium hypochlorite | 0.446034 |
| Naegleria fowleri infections | 0.608045 |
| household chlorine bleach | 0.699773 |
| water | 0.940933 |
| micron absolute filters | 0.43658 |
| Clin Infect Dis. | 0.547845 |
| daily hypertonic saline | 0.435221 |
| Zgierska A. Saline | 0.434443 |
| saline nasal irrigation | 0.581248 |
| Visvesvara GS | 0.43388 |
|
| Water Supply Preparation | 0.627615 |
| absolute pore size | 0.574802 |
| water likely increases | 0.498313 |
| sodium hypochlorite | 0.468734 |
| tap water | 0.718722 |
| micron absolute pore | 0.445033 |
| primary amebic meningoencephalitis | 0.784213 |
| neti pots | 0.460012 |
| Naegleria fowleri cysts | 0.562454 |
| Zafar A. Primary | 0.433597 |
| Naegleria fowleri | 0.883885 |
| drinking water | 0.796704 |
| Emergency Water Supply | 0.625823 |
| culturable Naegleria fowleri | 0.550576 |
| medicine dropper | 0.452372 |
| drinking water disinfection | 0.67108 |
| nasal passages | 0.516146 |
| disinfected water | 0.472738 |
| ritual nasal rinsing | 0.716829 |
| unscented liquid household | 0.560095 |
| nasal rinsing | 0.941434 |
| liquid household chlorine | 0.616533 |
| emergency drinking water | 0.635127 |
| Naegleria fowleri amebae | 0.554739 |
|
CLICK HERE |